-DOCSTART- -X- O
INTRODUCTION -X- _ O
: -X- _ O
Acute -X- _ B-Patient
respiratory -X- _ I-Patient
distress -X- _ I-Patient
syndrome -X- _ I-Patient
( -X- _ I-Patient
ARDS -X- _ I-Patient
) -X- _ I-Patient
has -X- _ O
heterogeneous -X- _ O
etiologies -X- _ O
, -X- _ O
rapid -X- _ O
progressive -X- _ O
change -X- _ O
and -X- _ O
a -X- _ O
high -X- _ O
mortality -X- _ O
rate. -X- _ O
To -X- _ O
improve -X- _ O
the -X- _ O
outcome -X- _ O
of -X- _ O
ARDS -X- _ O
, -X- _ O
accurate -X- _ O
diagnosis -X- _ O
is -X- _ O
essential -X- _ O
to -X- _ O
the -X- _ O
application -X- _ O
of -X- _ O
effective -X- _ O
early -X- _ O
treatment. -X- _ O
The -X- _ O
present -X- _ O
study -X- _ O
investigated -X- _ O
the -X- _ O
clinical -X- _ B-Intervention
effects -X- _ I-Intervention
and -X- _ I-Intervention
safety -X- _ I-Intervention
of -X- _ I-Intervention
open -X- _ I-Intervention
lung -X- _ I-Intervention
biopsy -X- _ I-Intervention
( -X- _ I-Intervention
OLB -X- _ I-Intervention
) -X- _ I-Intervention
in -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
early-stage -X- _ I-Patient
ARDS -X- _ I-Patient
of -X- _ I-Patient
suspected -X- _ I-Patient
non-infectious -X- _ I-Patient
origin. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
We -X- _ O
undertook -X- _ O
a -X- _ O
retrospective -X- _ O
study -X- _ O
of -X- _ O
41 -X- _ O
patients -X- _ B-Patient
with -X- _ I-Patient
early-stage -X- _ I-Patient
ARDS -X- _ I-Patient
( -X- _ O
defined -X- _ O
as -X- _ O
one -X- _ O
week -X- _ O
or -X- _ O
less -X- _ O
after -X- _ O
intubation -X- _ O
) -X- _ O
who -X- _ O
underwent -X- _ B-Intervention
OLB -X- _ I-Intervention
in -X- _ O
two -X- _ O
medical -X- _ O
intensive -X- _ O
care -X- _ O
units -X- _ O
of -X- _ O
a -X- _ O
tertiary -X- _ O
care -X- _ O
hospital -X- _ O
from -X- _ O
1999 -X- _ O
to -X- _ O
2005. -X- _ O
Data -X- _ O
analyzed -X- _ O
included -X- _ O
baseline -X- _ O
characteristics -X- _ O
, -X- _ O
complication -X- _ O
rate -X- _ O
, -X- _ O
pathological -X- _ O
diagnoses -X- _ O
, -X- _ O
treatment -X- _ O
alterations -X- _ O
, -X- _ O
and -X- _ O
hospital -X- _ O
survival. -X- _ O
RESULTS -X- _ O
: -X- _ O
The -X- _ O
age -X- _ O
of -X- _ O
patients -X- _ O
was -X- _ O
55 -X- _ O
± -X- _ O
17 -X- _ O
years -X- _ O
( -X- _ O
mean -X- _ O
± -X- _ O
SD -X- _ O
) -X- _ O
. -X- _ O
The -X- _ O
average -X- _ O
ratio -X- _ O
of -X- _ O
arterial -X- _ O
partial -X- _ O
pressure -X- _ O
of -X- _ O
oxygen -X- _ O
( -X- _ O
PaO -X- _ O
( -X- _ O
2 -X- _ O
) -X- _ O
) -X- _ O
to -X- _ O
fraction -X- _ O
of -X- _ O
inspired -X- _ O
oxygen -X- _ O
( -X- _ O
FiO -X- _ O
( -X- _ O
2 -X- _ O
) -X- _ O
) -X- _ O
was -X- _ O
116 -X- _ O
± -X- _ O
43 -X- _ O
mmHg -X- _ O
( -X- _ O
mean -X- _ O
± -X- _ O
SD -X- _ O
) -X- _ O
at -X- _ O
biopsy. -X- _ O
Seventeen -X- _ O
patients -X- _ O
( -X- _ O
41 -X- _ O
% -X- _ O
) -X- _ O
were -X- _ O
immunocompromised. -X- _ O
Postoperative -X- _ B-Outcome
complications -X- _ I-Outcome
occurred -X- _ I-Outcome
in -X- _ I-Outcome
20 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
patients -X- _ I-Outcome
( -X- _ I-Outcome
8 -X- _ I-Outcome
/ -X- _ I-Outcome
41 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
All -X- _ I-Outcome
biopsies -X- _ I-Outcome
provided -X- _ I-Outcome
a -X- _ I-Outcome
pathological -X- _ I-Outcome
diagnosis -X- _ I-Outcome
with -X- _ I-Outcome
a -X- _ I-Outcome
diagnostic -X- _ I-Outcome
yield -X- _ I-Outcome
of -X- _ I-Outcome
100 -X- _ I-Outcome
% -X- _ I-Outcome
. -X- _ I-Outcome
Specific -X- _ I-Outcome
pathological -X- _ I-Outcome
diagnoses -X- _ I-Outcome
were -X- _ I-Outcome
made -X- _ I-Outcome
for -X- _ I-Outcome
44 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
patients -X- _ I-Outcome
( -X- _ I-Outcome
18 -X- _ I-Outcome
/ -X- _ I-Outcome
41 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Biopsy -X- _ I-Outcome
findings -X- _ I-Outcome
led -X- _ I-Outcome
to -X- _ I-Outcome
an -X- _ I-Outcome
alteration -X- _ I-Outcome
of -X- _ I-Outcome
treatment -X- _ I-Outcome
modality -X- _ I-Outcome
in -X- _ I-Outcome
73 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
patients -X- _ I-Outcome
( -X- _ I-Outcome
30 -X- _ I-Outcome
/ -X- _ I-Outcome
41 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
treatment -X- _ I-Outcome
alteration -X- _ I-Outcome
rate -X- _ I-Outcome
was -X- _ I-Outcome
higher -X- _ I-Outcome
in -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
nonspecific -X- _ I-Outcome
diagnoses -X- _ I-Outcome
than -X- _ I-Outcome
in -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
specific -X- _ I-Outcome
diagnoses -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.0024 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Overall -X- _ I-Outcome
mortality -X- _ I-Outcome
was -X- _ I-Outcome
50 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
21 -X- _ I-Outcome
/ -X- _ I-Outcome
41 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
was -X- _ I-Outcome
not -X- _ I-Outcome
influenced -X- _ I-Outcome
by -X- _ I-Outcome
age -X- _ I-Outcome
, -X- _ I-Outcome
gender -X- _ I-Outcome
, -X- _ I-Outcome
pre-OLB -X- _ I-Outcome
oxygenation -X- _ I-Outcome
, -X- _ I-Outcome
complication -X- _ I-Outcome
rate -X- _ I-Outcome
, -X- _ I-Outcome
pathological -X- _ I-Outcome
results -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
alteration -X- _ I-Outcome
of -X- _ I-Outcome
treatment. -X- _ I-Outcome
There -X- _ O
was -X- _ O
no -X- _ O
surgery-related -X- _ O
mortality. -X- _ O
The -X- _ O
survival -X- _ O
rate -X- _ O
for -X- _ O
immunocompromised -X- _ O
patients -X- _ O
was -X- _ O
better -X- _ O
than -X- _ O
that -X- _ O
for -X- _ O
immunocompetent -X- _ O
patients -X- _ O
( -X- _ O
71 -X- _ O
% -X- _ O
versus -X- _ O
33 -X- _ O
% -X- _ O
; -X- _ O
p -X- _ O
= -X- _ O
0.0187 -X- _ O
) -X- _ O
in -X- _ O
this -X- _ O
study. -X- _ O
CONCLUSION -X- _ O
: -X- _ O
Our -X- _ O
retrospective -X- _ O
study -X- _ O
suggests -X- _ O
that -X- _ O
OLB -X- _ B-Outcome
was -X- _ I-Outcome
a -X- _ I-Outcome
useful -X- _ I-Outcome
and -X- _ I-Outcome
acceptably -X- _ I-Outcome
safe -X- _ I-Outcome
diagnostic -X- _ I-Outcome
procedure -X- _ I-Outcome
in -X- _ I-Outcome
some -X- _ I-Outcome
selected -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
early-stage -X- _ I-Outcome
ARDS -X- _ I-Outcome
. -X- _ O

